BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28483764)

  • 1. Polycomb repressive complexes in hematological malignancies.
    Iwama A
    Blood; 2017 Jul; 130(1):23-29. PubMed ID: 28483764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenic Impacts of Dysregulated Polycomb Repressive Complex Function in Hematological Malignancies.
    Kaito S; Iwama A
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deregulated Polycomb functions in myeloproliferative neoplasms.
    Sashida G; Oshima M; Iwama A
    Int J Hematol; 2019 Aug; 110(2):170-178. PubMed ID: 30706327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of the polycomb group proteins in the restriction of tumor development in hematological malignancies].
    Iwama A
    Rinsho Ketsueki; 2013 Jul; 54(7):642-8. PubMed ID: 23912347
    [No Abstract]   [Full Text] [Related]  

  • 5. Critical Roles of Polycomb Repressive Complexes in Transcription and Cancer.
    Dong GJ; Xu JL; Qi YR; Yuan ZQ; Zhao W
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycomb complexes in normal and malignant hematopoiesis.
    Di Carlo V; Mocavini I; Di Croce L
    J Cell Biol; 2019 Jan; 218(1):55-69. PubMed ID: 30341152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifaceted role of the polycomb-group gene EZH2 in hematological malignancies.
    Sashida G; Iwama A
    Int J Hematol; 2017 Jan; 105(1):23-30. PubMed ID: 27830540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycomb-group proteins in hematopoietic stem cell regulation and hematopoietic neoplasms.
    Radulović V; de Haan G; Klauke K
    Leukemia; 2013 Mar; 27(3):523-33. PubMed ID: 23257781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycomb complexes PRC1 and their function in hematopoiesis.
    Vidal M; Starowicz K
    Exp Hematol; 2017 Apr; 48():12-31. PubMed ID: 28087428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Deregulated polycomb complex function in the pathogenesis of MDS].
    Iwama A
    Rinsho Ketsueki; 2017; 58(6):654-660. PubMed ID: 28679998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycomb proteins in hematologic malignancies.
    Martin-Perez D; Piris MA; Sanchez-Beato M
    Blood; 2010 Dec; 116(25):5465-75. PubMed ID: 20716771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging role of noncanonical polycomb repressive complexes in normal and malignant hematopoiesis.
    Isshiki Y; Iwama A
    Exp Hematol; 2018 Dec; 68():10-14. PubMed ID: 30554637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of epigenetic changes in hematological malignancies.
    Lehmann U; Brakensiek K; Kreipe H
    Ann Hematol; 2004 Mar; 83(3):137-52. PubMed ID: 15064862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The roles of Polycomb group proteins in hematopoietic stem cells and hematological malignancies.
    Takamatsu-Ichihara E; Kitabayashi I
    Int J Hematol; 2016 Jun; 103(6):634-42. PubMed ID: 27086351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EZH2 in normal hematopoiesis and hematological malignancies.
    Herviou L; Cavalli G; Cartron G; Klein B; Moreaux J
    Oncotarget; 2016 Jan; 7(3):2284-96. PubMed ID: 26497210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation reprogramming in cancer: does it act by re-configuring the binding landscape of Polycomb repressive complexes?
    Reddington JP; Sproul D; Meehan RR
    Bioessays; 2014 Feb; 36(2):134-40. PubMed ID: 24277643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PER2: a potential molecular marker for hematological malignancies.
    Jiang H; Yang X; Mi M; Wei X; Wu H; Xin Y; Sun C
    Mol Biol Rep; 2021 Nov; 48(11):7587-7595. PubMed ID: 34642831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The polycomb group protein regulatory network.
    Mozgova I; Hennig L
    Annu Rev Plant Biol; 2015; 66():269-96. PubMed ID: 25621513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of mammalian SWI/SNF and polycomb complexes in human sarcomas: mechanisms and therapeutic opportunities.
    McBride MJ; Kadoch C
    J Pathol; 2018 Apr; 244(5):638-649. PubMed ID: 29359803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic abnormalities and therapies for hematological malignancies.
    Kitamura T
    Int J Hematol; 2019 Aug; 110(2):147-149. PubMed ID: 31280414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.